Social media personality Alabama Barker has publicly declared her intent to embark on an aggressive weight loss regimen, stating she will take the "highest dose of Ozempic" to become "so skinny" in direct response to persistent online body shaming. The daughter of Travis Barker and stepdaughter of Kourtney Kardashian made the controversial announcement in a TikTok video posted on July 30, signaling a dramatic shift in her approach to dealing with critics of her physical appearance. Her statement has ignited a broader discussion on celebrity body image, the ethics of GLP-1 medication use, and the profound impact of online bullying.
Barker’s recent TikTok clip captured immediate attention due to its confrontational tone and the specific mention of a potent prescription medication. In the video, she directly addressed her detractors, proclaiming, "This is not very role model of me, but I’m gonna get on the highest dose of Ozempic. I’m going to become so skinny, you’re gonna tell me I need a burger, because the way that people body shame me is f—— disgusting." She concluded the scathing message with defiant remarks, "I f—— hate you guys, and I’m gonna get so skinny. F— you. No a–, no t— in 2027. Bye," clearly indicating her frustration and a desire for extreme transformation.
This recent declaration is not Barker’s first public acknowledgment of her struggles with body image and weight. In a previous TikTok video in July 2024, she disclosed that she was already using weight-loss medication, explaining her decision stemmed from feeling "tired of being fat and photographing like a damn ogre." She elaborated on the psychological toll of online comments, noting, "I have like this thing where I photograph so ugly, and people are like, ‘Oh my God, you’re so fat and you’re so ugly.’" The pressure from these comments evidently led her to seek medical intervention for weight loss.
Adding another layer of complexity to her health journey, Barker revealed in 2023 that she contends with a thyroid condition and an autoimmune disease. These medical issues, she explained, are significant factors contributing to her fluctuating weight. At the time, she expressed concern for her young followers, stating, "Weight fluctuates and I don’t want any girls that are young watching this that are gaining weight to ever think there’s something wrong with it." This past sentiment contrasts sharply with her latest, more aggressive stance on weight loss, highlighting the intense internal and external pressures she faces.
The mention of Ozempic, a brand name for semaglutide, immediately drew significant attention. Originally approved for the treatment of Type 2 diabetes, Ozempic belongs to a class of drugs known as GLP-1 receptor agonists. These medications work by mimicking a hormone that targets areas of the brain involved in appetite regulation, leading to reduced hunger and increased feelings of fullness. While highly effective for managing blood sugar in diabetics, its profound side effect of weight loss has led to widespread off-label use, particularly within celebrity and social media circles. This surge in demand has sparked ethical debates and concerns about drug availability for those with Type 2 diabetes who rely on it for essential health management.
The medical community has consistently cautioned against the unsupervised or purely cosmetic use of powerful prescription drugs like Ozempic. Potential side effects can range from gastrointestinal issues like nausea, vomiting, and diarrhea to more severe complications such as pancreatitis, gallbladder problems, and kidney injury. Long-term effects for individuals without diabetes using these medications primarily for weight loss are still being studied. Experts stress that any decision to use such medication should be made in consultation with a healthcare professional, considering individual health profiles and potential risks.
Barker’s public declaration reflects a growing trend among public figures who openly discuss their use of GLP-1 drugs for weight management. This transparency, while sometimes praised for destigmatizing weight loss efforts, also raises questions about the influence celebrities wield over their often young and impressionable audiences. When an influencer, especially one with a large following, discusses taking the "highest dose" of a potent drug to achieve extreme thinness, it can inadvertently promote potentially unhealthy body ideals and dangerous approaches to weight loss. The pressure to conform to unrealistic beauty standards, amplified by social media, can have detrimental effects on the mental and physical health of young individuals.
Body shaming, the practice of criticizing or mocking someone for their body shape or size, remains a pervasive issue on social media platforms. Public figures, particularly women, are disproportionately targeted, facing intense scrutiny over every aspect of their appearance. This constant barrage of negative comments can lead to significant psychological distress, including anxiety, depression, body dysmorphia, and disordered eating. Despite her previous advice to ignore online trolls, stating that "online trolls ‘are going to hate regardless’" and encouraging others to "not feed into it," Barker’s latest comments suggest that even her own resilience has been tested by the relentless criticism.
The Kardashian-Jenner family, of which Alabama Barker is a stepdaughter, has a long history of navigating public scrutiny regarding body image and beauty standards. The family members have frequently been at the forefront of discussions about cosmetic procedures, fitness regimens, and the pursuit of idealized physiques. This familial context may offer some insight into the intense pressure Barker experiences, existing within a sphere where physical appearance is often meticulously analyzed and critiqued. Her journey underscores the significant challenges faced by young individuals growing up in the public eye, constantly battling external expectations and internal struggles with self-perception.
As the conversation around Ozempic and other GLP-1 medications continues to evolve, Barker’s outspoken stance adds another dimension to the debate. Her announcement will likely spark further discussion among health professionals, parents, and social media users about the responsibilities of influencers, the impact of body shaming, and the safe and ethical use of powerful pharmaceuticals. While her candidness might resonate with some who feel similarly targeted by online criticism, her approach to seeking extreme thinness through medical means also highlights the complex and often distressing intersection of celebrity culture, personal vulnerability, and public health.
